Leal, A. D., Blatchford, P. J., Kim, S. S., Lentz, R. W., Kemme, D. J., Russen, M., Friedrich, T., Mathew, L., Hoyer, R. J., Kono, S. A., Toegel, E. B., Bagby, S. M., Dominguez, A., Davis, S. L., Pitts, T., Lieu, C. H., Messersmith, W. A. (2025). Phase II study of cabozantinib and nivolumab in refractory metastatic microsatellite stable (MSS) colorectal cancer (CRC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.229